Date: Dec 15, 2010 Source: (
click here to go to the source)
Auritec Pharmaceuticals, a privately held drug development company focused on sustained release delivery of therapeutics, announces the selection of Destum Partners, Inc. to identify, evaluate, and secure strategic partnerships for its Plexis and Versa drug delivery platforms.
"The Management Team and Board of Directors of Auritec carefully evaluated all available options, and believe that the experience, industry focus, and the impressive track record of Destum Partners are ideally suited to meet our strategic partnering objectives", stated Thomas Smith, CEO of Auritec Pharmaceuticals. Partners has completed a compelling analysis of the current market potential for these sustained release drug delivery technologies and is quickly moving forward with this opportunity.
